Bambusa Therapeutics $BBTX

Recent News (3)

• Bambusa Therapeutics prices upsized IPO at $16 per share Investing.com · 30 Oct 2026 Bambusa Therapeutics prices upsized IPO at $16 per share
• Bambusa Therapeutics Announces Pricing of Upsized Initial Public Offering PR Newswire · 30 Oct 2026 BOSTON, Oct. 29, 2026 /PRNewswire/ -- Bambusa Therapeutics, Inc. (Nasdaq: BBTX) ("Bambusa Therapeutics" or "Bambusa"), a clinical-stage biopharmaceutical company developing next-generation, long-actin…
• Aspen Neuroscience, Bambusa Therapeutics launch US IPOs as biotech boom rolls on Investing.com · 26 Oct 2026 Aspen Neuroscience, Bambusa Therapeutics launch US IPOs as biotech boom rolls on